Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zandra Olivecrona, Lukas Bobinski & Lars-Owe D. Koskinen. (2015) Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers. Brain Injury 29:4, pages 446-454.
Read now
Read now
Frank Martin Schmidt, Roland Mergl, Barbara Stach, Ina Jahn & Peter Schönknecht. (2015) Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. The World Journal of Biological Psychiatry 16:2, pages 106-113.
Read now
Read now
J. Finsterer, M. Exner & H. Rumpold. (2004) Cerebrospinal fluid neuron‐specific enolase in non‐selected patients. Scandinavian Journal of Clinical and Laboratory Investigation 64:6, pages 553-558.
Read now
Read now
Articles from other publishers (33)
Akihiro Tsukahara, Takafumi Hosokawa, Daisuke Nishioka, Takuya Kotani, Shimon Ishida, Tohru Takeuchi, Fumiharu Kimura & Shigeki Arawaka. (2021) Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy. Scientific Reports 11:1.
Crossref
Crossref
Agneta H. Snoer, Anne Luise H. Vollesen, Rasmus Paulin Beske, Song Guo, Jan Hoffmann, Niklas R. Jørgensen, Torben Martinussen, Messoud Ashina & Rigmor H. Jensen. (2020) S100B and NSE in Cluster Headache – Evidence for Glial Cell Activation?. Headache: The Journal of Head and Face Pain 60:8, pages 1569-1580.
Crossref
Crossref
O. Chai, M. Mazaki-Tovi, S. Klainbart, E. Kelmer, A. Shipov & M.H. Shamir. (2020) Serum Concentrations of Neuron-Specific Enolase in Dogs Following Traumatic Brain Injury. Journal of Comparative Pathology 179, pages 45-51.
Crossref
Crossref
Hiroshi Takahashi, Yasuchika Aoki, Arata Nakajima, Masato Sonobe, Fumiaki Terajima, Masahiko Saito, Takuya Miyamoto, Keita Koyama, Keiichiro Yamamoto, Takeo Furuya, Masao Koda, Seiji Ohtori, Masashi Yamazaki & Koichi Nakagawa. (2018) Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples. European Spine Journal 27:8, pages 1824-1830.
Crossref
Crossref
Richard W. Issitt, Ian Harvey, Bronagh Walsh & David Voegeli. (2017) Quantification of Lipid Filtration and the Effects on Cerebral Injury During Cardiopulmonary Bypass. The Annals of Thoracic Surgery.
Crossref
Crossref
Keisuke Kawata, Charles Y. Liu, Steven F. Merkel, Servio H. Ramirez, Ryan T. Tierney & Dianne Langford. (2016) Blood biomarkers for brain injury: What are we measuring?. Neuroscience & Biobehavioral Reviews 68, pages 460-473.
Crossref
Crossref
E. Gordillo-Escobar, J.J. Egea-Guerrero, A. Rodríguez-Rodríguez & F. Murillo-Cabezas. (2016) Usefulness of biomarkers in the prognosis of severe head injuries. Medicina Intensiva (English Edition) 40:2, pages 105-112.
Crossref
Crossref
E. Gordillo-Escobar, J.J. Egea-Guerrero, A. Rodríguez-Rodríguez & F. Murillo-Cabezas. (2016) Utilidad de los biomarcadores en el pronóstico del traumatismo craneoencefálico grave. Medicina Intensiva 40:2, pages 105-112.
Crossref
Crossref
Marcus W. Koch, Suzanne George, Winona Wall, V. Wee Yong & Luanne M. Metz. (2015) Serum NSE level and disability progression in multiple sclerosis. Journal of the Neurological Sciences 350:1-2, pages 46-50.
Crossref
Crossref
Frederick G. Strathmann, Stefanie Schulte, Kyle Goerl & David J. Petron. (2014) Blood-based biomarkers for traumatic brain injury: Evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clinical Biochemistry 47:10-11, pages 876-888.
Crossref
Crossref
Ursula K Rohlwink & Anthony A Figaji. (2014) Biomarkers of Brain Injury in Cerebral Infections. Clinical Chemistry 60:6, pages 823-834.
Crossref
Crossref
L. Wanke-Jellinek & P. Biberthaler. (2013) Serummarker nach Schädel-Hirn TraumaSerum parameters after traumatic brain injury. Trauma und Berufskrankheit 15:S2, pages 107-114.
Crossref
Crossref
Sameh El-Maraghi, Heba Yehia, Hazem Hossam, Ahmed Yehia & Hossam Mowafy. (2013) The prognostic value of neuron specific enolase in head injury. The Egyptian Journal of Critical Care Medicine 1:1, pages 25-32.
Crossref
Crossref
Shahrokh Yousefzadeh Chabok, Anoush Dehnadi Moghadam, Zahra Saneei, Fatemeh Ghazanfari Amlashi, Ehsan Kazemnezhad Leili & Zahra Mohtasham Amiri. (2012) Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury. Journal of Trauma and Acute Care Surgery 72:6, pages 1654-1657.
Crossref
Crossref
Sabrina Giacoppo, Placido Bramanti, Marina Barresi, Debora Celi, Valeria Foti Cuzzola, Eleonora Palella & Silvia Marino. (2012) Predictive Biomarkers of Recovery in Traumatic Brain Injury. Neurocritical Care 16:3, pages 470-477.
Crossref
Crossref
Brankica Vasiljevic, Svjetlana Maglajlic‐Djukic, Miroslava Gojnic, Sanja Stankovic, Svetlana Ignjatovic & Dragana Lutovac. (2011) New insights into the pathogenesis of perinatal hypoxic‐ischemic brain injury. Pediatrics International 53:4, pages 454-462.
Crossref
Crossref
Nurgul Yılmaz, Kamil Karaali, Sebahat Ozdem, Mehtap Turkay, Ali Unal & Babur Dora. (2011) Elevated S100B and Neuron Specific Enolase Levels in Patients with Migraine-without Aura: Evidence for Neurodegeneration?. Cellular and Molecular Neurobiology 31:4, pages 579-585.
Crossref
Crossref
Basel Ramlawi & Frank W. Sellke. 2011. Brain Protection in Cardiac Surgery. Brain Protection in Cardiac Surgery
45
55
.
Erzsébet Kövesdi, János Lückl, Péter Bukovics, Orsolya Farkas, József Pál, Endre Czeiter, Dóra Szellár, Tamás Dóczi, Sámuel Komoly & András Büki. (2009) Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochirurgica 152:1, pages 1-17.
Crossref
Crossref
Rachel Berger & Rudolph Richichi. (2009) Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum. Pediatric Critical Care Medicine 10:2, pages 260-263.
Crossref
Crossref
Michael Teepker, Karoline Munk, Veit Mylius, Anja Haag, Jens C. Möller, Wolfgang H. Oertel & Karsten Schepelmann. (2009) Serum Concentrations of s100b and NSE in Migraine. Headache: The Journal of Head and Face Pain 49:2, pages 245-252.
Crossref
Crossref
Natheer H. Al-Rawi & Karim M. Atiyah. (2009) Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients. Clinical Chemistry and Laboratory Medicine 47:12.
Crossref
Crossref
Odile Carrette, Pierre R. Burkhard, Denis F. Hochstrasser & Jean‐Charles Sanchez. (2006) Age‐related proteome analysis of the mouse brain: a 2‐DE study. PROTEOMICS 6:18, pages 4940-4949.
Crossref
Crossref
Basel Ramlawi, James L. Rudolph, Shigetoshi Mieno, Kamal Khabbaz, Neel R. Sodha, Munir Boodhwani, Sue E. Levkoff, Edward R. Marcantonio & Frank W. Sellke. (2006) Serologic Markers of Brain Injury and Cognitive Function After Cardiopulmonary Bypass. Transactions of the ... Meeting of the American Surgical Association 124, pages 258-266.
Crossref
Crossref
Linda E Pelinka, Harald Hertz, Walter Mauritz, Naoki Harada, Mohammad Jafarmadar, Manfred Albrecht, Heinz Redl & Soheyl Bahrami. (2005) NONSPECIFIC INCREASE OF SYSTEMIC NEURON-SPECIFIC ENOLASE AFTER TRAUMA: CLINICAL AND EXPERIMENTAL FINDINGS. Shock 24:2, pages 119-123.
Crossref
Crossref
M. Casmiro, S. Maitan, F. De Pasquale, V. Cova, E. Scarpa & L. Vignatelli. (2005) Cerebrospinal fluid and serum neuron‐specific enolase concentrations in a normal population*. European Journal of Neurology 12:5, pages 369-374.
Crossref
Crossref
Jose A. Pineda, Kevin K. W. Wang & Ronald L. Hayes. (2006) Biomarkers of Proteolytic Damage Following Traumatic Brain Injury. Brain Pathology 14:2, pages 202-209.
Crossref
Crossref
J.R. Infante, A. Martínez, J. Ochoa, F. Cañadillas, M. Torres-Avisbal, J.A. Vallejo, F.M. González, C. Pacheco & J.M. Latre. (2003) Niveles de S-100 y enolasa neuroespecífica en líquido cefalorraquídeo de enfermos con patología neurológica. Revista Española de Medicina Nuclear 22:4, pages 238-243.
Crossref
Crossref
Tor Ingebrigtsen & Bertil Romner. (2002) Biochemical Serum Markers of Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care 52:4, pages 798-808.
Crossref
Crossref
Rachel Pardes Berger, Mary Clyde Pierce, Stephen R. Wisniewski, P. David Adelson, Robert S. B. Clark, Randy A. Ruppel & Patrick M. Kochanek. (2002) Neuron-Specific Enolase and S100B in Cerebrospinal Fluid After Severe Traumatic Brain Injury in Infants and Children. Pediatrics 109:2, pages e31-e31.
Crossref
Crossref
Dirk Völkel, Klaus Zimmermann, Inga Zerr, Thomas Lindner, Monica Bodemer, Sigrid Poser & Hans Peter Schwarz. (2002) C‐reactive protein and IL‐6: new marker proteins for the diagnosis of CJD in plasma?. Transfusion 41:12, pages 1509-1514.
Crossref
Crossref
SW Van Gool, E Van Kerschaver, P Brock, H Pottel, F Hulstaert, E Vanmechelen, A Uyttebroeck, A Van De Voorde & H Vanderstichele. (2000) Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies. Leukemia 14:12, pages 2076-2084.
Crossref
Crossref
E.C. Creutzberg, A.M.W.J. Schols, F.C.M. Bothmer-Quaedvlieg, G. Wesseling & E.F.M. Wouters. (1998) Acute Effects of Nebulized Salbutamol on Resting Energy Expenditure in Patients with Chronic Obstructive Pulmonary Disease and in Healthy Subjects. Respiration 65:5, pages 375-380.
Crossref
Crossref